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ed March 26, 2013.his study sought to perform a systematic review and meta-analysis to understand the role of stress cardiac
magnetic resonance imaging (CMR) in assessing cardiovascular prognosis in patients with known or suspected
coronary artery disease (CAD).Background Although stress CMR is excellent for the diagnosis of obstructive CAD, the prognostic value of stress CMR has been
less well described.Methods PubMed, Cochrane CENTRAL, and metaRegister of Controlled Trials were searched for stress CMR studies with
>6 months of prognostic data. Primary endpoints were cardiovascular death, myocardial infarction (MI), and
a composite outcome of cardiovascular death or MI during follow-up. Summary effect estimates were generated
with random-effects modeling, and annualized event rates were assessed.Results Nineteen studies (14 vasodilator, 4 dobutamine, and 1 that used both) involved a total of 11,636 patients with
a mean follow-up of 32 months. Patients had a mean age of 63  12 years, 63% were male, and 26% had previous
MI; mean left ventricular ejection fraction was 61  12%; and late gadolinium enhancement was present in 29%
and ischemia in 32%. Patients with ischemia had a higher incidence of MI (odds ratio [OR]: 7.7; p < 0.0001),
cardiovascular death (OR: 7.0; p < 0.0001), and the combined endpoint (OR: 6.5; p < 0.0001) compared with those
with a negative study. The combined outcome annualized events rates were 4.9% for a positive versus 0.8% for
a negative stress CMR (p < 0.0001), 2.8% versus 0.3% for cardiovascular death (p < 0.0001), and 2.6% versus
0.4% for MI (p < 0.0005). The presence of late gadolinium enhancement was also signiﬁcantly associated with
a worse prognosis.Conclusions A negative stress CMR study is associated with very low risk of cardiovascular death and MI. Stress CMR has
excellent prognostic characteristics and may help guide risk stratiﬁcation of patients with known or suspected CAD.
(J Am Coll Cardiol 2013;62:826–38) ª 2013 by the American College of Cardiology FoundationStress cardiac magnetic resonance imaging (CMR), either
with vasodilator or dobutamine stress, has been shown to
have excellent diagnostic accuracy for detection of signiﬁcant
coronary artery disease (CAD) (1–4). In addition, CMR
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2012; revised manuscript received February 24,ventricular function, the presence of late gadolinium
enhancement (LGE), and whether there is structural or
valvular heart disease. As a result, stress CMR is increasinglySee page 839being used to assess chest pain in patients with known or
suspected CAD. In addition, stress CMR may have a role
after ST-segment elevation myocardial infarction (MI) to
assess for residual ischemia due to coronary stenoses in
noninfarct-related arteries (5,6). Furthermore, stress CMR
can be used in patients with dilated cardiomyopathy to assess
for ischemia and myocardial scar burden with LGE (7,8).
Given the increasing health care costs associated with
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827cardiovascular imaging, it is critical to validate the prognostic
utility of stress CMR (9,10).
Over the past several years, multiple studies have been
published regarding stress CMR assessment of prognosis.
However, many of these studies are limited because they are
small and single centered. Prognostic validation of stress CMR
is critical because a negative stress CMR can be reassuring that
the patient has a very low risk for major adverse cardiovascular
events (MACE). Alternatively, patients with stress-induced
wall motion abnormalities, abnormal perfusion, and/or LGE
are at higher risk of MACE. In the current environment of
escalating medical costs, the prognostic performance of stress
CMR may also help justify its use compared with more
commonly used stress modalities such as stress echocardiog-
raphy and stress nuclear perfusion imaging. Given themultiple
small and single-centered studies, we performed a systematic
review and meta-analysis of studies reporting prognostic data
from patients undergoing stress CMR to assess for myocardial
ischemia in those with known or suspected CAD.Figure 1 Flow Diagram of the Review Process
CMR ¼ cardiac magnetic resonance imaging.Methods
Eligibility criteria. We included any of the following: 1)
study assessing for myocardial ischemia with stress CMR; 2)
with 6 months of prognostic follow-up data, including
cardiac death and/or MI; and 3) excluding populations
composed of patients with cardiomyopathy or acute MI
within the last 14 days.
Search strategy. To identify eligible studies for inclusion in
the current systematic review and meta-analysis, 2 inde-
pendent reviewers (M.J.L. and C.M.M.) systematically
searched (October 2012) Cochrane CENTRAL, meta-
Register of Controlled Trials, and PubMed for studies
assessing prognosis in patients with known or suspected
CAD after undergoing stress CMR. Key words used were
“prognosis” OR “outcome” AND “stress magnetic resonance
imaging” or “dobutamine magnetic resonance imaging” or
“adenosine magnetic resonance imaging.” In addition, we
consulted experts, reviewed citations from eligible studies,
and explored “see related articles” for key publications in
PubMed. The search was limited to studies published in
peer-reviewed journals and thus excludes trials presented in
abstract form only. We restricted the review to studies that
enrolled adults only. No language restriction was applied.
The current systematic review and meta-analysis was per-
formed in accordance with guidelines of the MOOSE
(Meta-analysis of Observational Studies in Epidemiology)
and PRISMA (Preferred Reporting Items for Systematic
Reviews and Meta-Analyses ) groups (11,12).
Study selection. Two investigators (M.J.L. and C.M.M.)
independently and in duplicate scanned all abstracts and
obtained full-text reports of articles that indicated or sug-
gested eligibility. After obtaining full reports, the same
reviewers independently assessed eligibility from the full-text
articles, with divergences resolved after consensus. Study
quality was evaluated by the Newcastle-Ottawa QualityAssessment Scale for Cohort
Studies (13), in which the quality
of the selected trials was deter-
mined on the basis of selection of
the study groups (0 to 4 points),
comparability of the study groups
(0 to 2 points), and ascertain-
ment of the outcome of interest
(0 to 3 points).
Data collection. Data abstrac-
tion and study appraisal were
performed by the same 2 afore-
mentioned investigators. Clinical
outcomes of interest were
cardiovascular death, MI, or the composite outcome of
cardiovascular death or MI during follow-up. Clinical
outcomes data were directly abstracted when reported.
Unadjusted hazard ratios were used to determine the
number of events if not provided for each group, and
Table 1 Study Characteristics
Stress CMR Studies
First Author (Ref. #)
Year
Published
No. of
Patients
Included
Follow-Up
(Months) Stress Agent Study Design
Quality
Assessment
Score
Field
Strength (T)
Deﬁnition of
Positive
Stress CMR Population
Bertaso et al. (38) 2012 362 22 Adenosine Retrospective,
single-center
3/2/3 1.5 Reversible perfusion
defect
Consecutive patients
referred for stress
CMR
Bingham et al. (39) 2011 908 31  14 Adenosine Prospective,
single-center
4/2/3 1.5 Stress perfusion defect.
No resting perfusion
performed
Consecutive patients
referred for stress
CMR
Bodi et al. (40) 2012 1,722 13  11 Dipyridamole Prospective,
multicenter
4/2/3 1.5 Reversible perfusion
defect in at least one
segment
Patients with chest pain
or to assess ischemia
in intermediate
coronary stenoses
Buckert et al. (41) 2013 1,152 50  25 Adenosine Prospective,
single-center
4/2/3 1.5 Reversible perfusion
defect extending
beyond any area of
LGE
Patients with stable
angina referred for
stress CMR
Coelho-Filho et al. (42) 2011 405 30 92% Adenosine
8% Dipyridamole
Prospective,
single-center
4/2/3 1.5 or 3.0 Stress perfusion defect
without matching
segmental LGE
Consecutive patients
referred for stress
CMR
Doesch et al. (43) 2009 81 30  8 Adenosine Prospective,
single-center
4/2/3 1.5 Reversible perfusion
defect extending
beyond any area of
LGE
Assessment of
ischemia in patients
with intermediate
coronary stenoses
Ingkanisorn et al. (44) 2006 135 16 Adenosine Prospective,
single-center
4/2/3 1.5 Reversible perfusion
defect in >1
segment
Patients with chest pain
and negative
troponins referred
from the ED
Jahnke et al. (45) 2011 679 57  26 Adenosine and
dobutamine
Retrospective,
single-center
3/2/3 1.5 Reversible perfusion
defect
Consecutive patients to
assess chest pain or
dyspnea for
combined stress
adenosine or
dobutamine CMR
Krittayaphong et al. (46) 2011 1,232 35 16 Adenosine Retrospective,
single-center
3/2/3 1.5 Reversible perfusion
defect extending
beyond any area of
LGE
All patients age >18
years referred for
stress CMR
Lerakis et al. (47) 2009 103 9 (5–15) Adenosine Retrospective,
single-center
3/1/3 1.5 Perfusion defect at rest
or stress, resting wall
motion abnormality,
or LGE
Patients with low-risk
chest pain referred
from the ED
Lo et al. (48) 2011 203 38  19 Adenosine Retrospective,
single-center
3/2/3 1.5 Reversible perfusion
defect
Patients with known or
suspected CAD to
assess for ischemia
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Table 1 Continued
Stress CMR Studies
First Author (Ref. #)
Year
Published
No. of
Patients
Included
Follow-Up
(Months) Stress Agent Study Design
Quality
Assessment
Score
Field
Strength (T)
Deﬁnition of
Positive
Stress CMR Population
Lubbers et al. (49) 2012 125 22 (11 to 43) Adenosine Prospective,
single-center
3/2/3 1.5 Perfusion defect in
>2 segments (or
1 segment at apex)
Consecutive patients
referred from
outpatient cardiology
clinic to assess for
ischemia
Pilz et al. (50) 2008 218 12 Adenosine Prospective,
single-center
3/2/3 1.5 Only negative tests
included
Patients with suspected
CAD but adenosine
CMR negative for
ischemia or LGE
Steel et al. (51) 2009 254 17 (8–56) 89% Adenosine
11% Dipyridamole
Retrospective,
single-center
3/2/3 1.5 Reversible perfusion
defect in at least
1 segment.
Patients with chest pain
referred for stress
CMR
Vogel-Claussen et al.
(52)
2009 27 14  5 Adenosine Prospective,
single-center
4/1/3 1.5 Reversible perfusion
defect
Patients with low-risk
chest pain referred
from the ED
Charoenpanichkit et al.
(53)
2010 353 72  24 Dobutamine Prospective,
single-center
4/2/3 1.5 New or worsening
stress-induced wall
motion abnormality
in >1 segment
Consecutive patients
referred for stress
CMR
Gebker et al. (54) 2011 1,167 25  10 Dobutamine Prospective,
single-center
4/2/3 1.5 New or worsening
stress-induced wall
motion abnormality
in >1 segment, or
a biphasic response
Consecutive patients to
assess chest pain or
dyspnea
Kelle et al. (55) 2011 1,017 44  24 Dobutamine Retrospective,
single-center
3/2/3 1.5 New or worsening
stress-induced wall
motion abnormality
in >1 segment or
a biphasic response
Patients with known or
suspected CAD to
assess for ischemia
Korosoglou et al. (56) 2010 1,493 24  12 Dobutamine Retrospective,
single-center
3/2/3 1.5 New or worsening
stress induced wall
motion abnormality
in >1 segment
Consecutive patients
with known or
suspected CAD to
assess for ischemia
CAD ¼ coronary artery disease; CMR ¼ cardiac magnetic resonance imaging; ED ¼ emergency department; LGE ¼ late gadolinium enhancement.
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830annualized event rates (AERs) for studies were calculated by
dividing the number of events by the follow-up duration.
Data analysis. Dichotomous variables are reported as
proportions (percentages); continuous variables are reported
as mean  SD or median (range). Binary outcomes from
individual studies were combined with a random-effects
model, leading to computations of odds ratios (ORs) with
95% conﬁdence intervals (CIs). I2 was calculated as
a measure of statistical heterogeneity, with I2 values of 25%,
50%, and 75% representing mild, moderate, and severe
inconsistency, respectively. Small study or publication bias
was explored with funnel plots, Egger’s test (14), and Peters’
test (15). Finally, meta-regression and sensitivity analyses
(including exclusion of 1 study at a time) were conducted to
explore heterogeneity.
Statistical analysis was performed by using Review
Manager (RevMan) 5 version 5.1.7 freeware package
(Copenhagen: The Nordic Cochrane Centre, The Cochrane
Collaboration, 2008) and NCSS 2007 (NCSS LLC,
Kaysville, Utah), with statistical signiﬁcance for hypothesis
testing set at the 0.05 two-tailed level. AERs were compared
by using weighted comparison of means in which we provide
SD and SE of the difference of the means to provide
signiﬁcance by the Student’s t test (16).Results
Results of the literature search. Our literature search
identiﬁed 2,019 relevant abstracts of full-text articles; of
these, 58 unique articles were abstracted for review. Forty-
ﬁve of these articles warranted full-text review. Twenty-six
articles (5–9,17–37) were excluded for various reasons,
including cohort overlap with other articles or lack of our
prespeciﬁed outcomes, leaving 19 articles for detailed study
(38–56). The details of our ﬂow diagram can be found in
Figure 1, and study characteristics are presented in Table 1.
Only 1 study included patients undergoing stress CMR at
3.0-T and 1.5-T; the rest of the studies were performed at
1.5-T.
The 19 studies with a weighted mean follow-up of 32
months (median 25months; range 9 to 72months) included a
total of 11,636 patients with known or suspected CAD un-
dergoing stress CMR (14 vasodilator stress [38–44,46–52];
4 dobutamine stress [53–56]; and 1 using both vasodilator and
dobutamine stress [45]) (median 362 patients; average 612
patients [range: 27 to 1,722]). Patients had a weighted mean
age of 63  12 years, and 63% of patients were male. The
population also had a typical distribution of cardiovascular risk
factors: 42% with CAD, 26% with previous MI, 66% with
hypertension, 60% with hyperlipidemia, 24% with diabetes
mellitus, and 25% with a history of smoking. With regard to
stress CMR, the weighted mean left ventricular ejection
fraction was 61  12%, LGE was present in 29% of patients
when reported, and 32% of patients had a positive stress
CMR. Baseline patient characteristics are demonstrated in
Table 2.Evidence of ischemia in stress CMR and cardiovascular
outcome. Of the 19 studies reporting the combined
outcome of cardiovascular death and MI during follow-up
(Fig. 2A), patients with a positive stress CMR had a
greater incidence of the combined outcome compared with
patients who had a negative stress CMR (OR: 6.5 [95% CI:
4.41 to 9.58]; p < 0.00001, I2 ¼ 74%). There was no
signiﬁcant difference between the prognostic characteristics
of vasodilator and dobutamine stress CMR. Patients with
a positive stress CMR had a signiﬁcantly greater AER of the
combined outcome (Table 3, Fig. 3) than patients with
a negative stress CMR (4.9  3.1% vs. 0.8  0.7%,
respectively; T score ¼ 5.69, p < 0.000002). There was no
signiﬁcant difference in the combined outcome AERs for
patients undergoing vasodilator stress CMR versus dobut-
amine stress CMR in patients with a positive stress CMR
(4.9  3.5% vs. 4.7  2.4%, respectively; T score ¼ 0.15,
p ¼ 0.89) or in patients with a negative stress CMR (0.9 
0.8% vs 0.7  0.7%; T score ¼ 0.58, p ¼ 0.57).
Of the 13 studies reporting cardiovascular death during
follow-up (Fig. 2B), patients with a positive stress CMR
had a signiﬁcantly greater risk of cardiovascular death
during follow-up compared with patients who had a nega-
tive stress CMR (OR: 6.96 [95% CI: 4.13 to 11.74];
p < 0.00001, I2 ¼ 36%). When comparing the cardiovas-
cular death AERs (Table 3, Fig. 3), patients with a positive
stress CMR had signiﬁcantly greater risk of cardiovascular
death during follow-up than patients with a negative stress
CMR(2.8 1.6%vs. 0.3 0.3%, respectively;T score¼ 5.58,
p < 0.00002).
Of the 13 studies reporting nonfatal MI during follow-up
(Fig. 2C), patients with a positive stress CMR had a
signiﬁcantly higher incidence of MI during follow-up
compared with patients who had a negative stress CMR
(OR: 7.73 [95% CI: 3.28 to 18.23]; p < 0.00001, I2 ¼ 73%).
When comparing the MI AERs (Table 3, Fig. 3), patients
with a positive stress CMR had a signiﬁcantly higher inci-
dence of MI during follow-up than patients with a negative
stress CMR (2.6  2.0% vs. 0.4  0.3%, respectively;
T score ¼ 4.1, p < 0.0005).
Meta-regression analysis was performed to determine
whether any clinical variables were associated with the
combined cardiovascular outcome, cardiovascular death, or
nonfatal MI. All variables from Table 2 were included in the
meta-regression. Meta-regression analysis demonstrated that
only previous MI (correlation –0.64; R2 ¼ 0.41; p < 0.04)
was associated with an increased incidence of combined
cardiovascular outcomes. Among the studies reporting LGE,
there was a signiﬁcant correlation between previous MI
and LGE (correlation 0.98; R2 ¼ 0.96; p < 0.0001).
LGE during stress CMR and cardiovascular outcomes. Of
the 10 studies reporting the combined outcome of cardio-
vascular death and MI during follow-up and presence of
LGE (Fig. 4A), patients with evidence of LGE had a worse
outcome than patients without LGE (OR: 3.82 [95% CI:
2.56 to 5.71]; p < 0.00001, I2 ¼ 46%). When comparing the
Table 2 Baseline Patient Characteristics
Stress CMR Studies
First Author (Ref. #)
Age
(yrs)
Male
(%)
Known
CAD (%)
Prior
Revascularization
(%)
Prior PCI
(%)
Prior
CABG
(%)
Prior MI
(%)
Hypertension
(%)
Hyperlipidemia
(%)
Diabetes
Mellitus
(%)
Smoking
history
(%)
LVEF
(%)
LGE
Present
(%)
Positive
Stress
(%)
Bertaso et al. (38) 62  12 58 43 NR NR 0 NR 58 60 24 24 67  12 21 25
Bingham et al. (39) 65 59 49 NR 33 15 35 64 NR 25 6 63 38 33
Bodi et al. (40) 64  11 62 NR NR 14 7 23 62 55 28 22 62  13 28 41
Buckert et al. (41) 62  12 72 NR NR 41 12 36 63 57 21 24 64  13 41 27
Coelho-Filho et al. (42) 57  14 59 NR NR 16 8 20 56 57 22 15 57  13 30 31
Doesch et al. (43) 64  10 83 100 35 27 7 30 72 58 28 40 56  10 NR 56
Ingkanisorn et al. (44) 56  14 56 17 12 NR NR 7 42 53 10 30 65  11 10 21
Jahnke et al. (45) 61  10 69 54 48 NR NR 24 78 74 23 35 57  8 NR 48/41
Krittayaphong et al. (46) 65  11 48 12 11 NR NR NR 63 62 35 15 64  17 27 34
Lerakis et al. (47) 57  12 37 13 NR NR NR NR 64 39 29 19 NR 5 10
Lo et al. (48) 62  12 59 16 NR 12 3 10 70 46 30 29 65  13 13 21
Lubbers et al. (49) 61  11 54 NR NR NR NR 0 46 86 15 63 NR NR 10
Pilz et al. (50) 63  13 56 0 0 0 0 0 68 37 9 35 61  9 0 0
Steel et al. (51) 58  13 59 NR 26 18 11 22 57 61 25 11 58  11 28 29
Vogel-Claussen
et al. (52)
56  13 56 19 19 4 15 NR 78 78 33 67 NR 15 19
Charoenpanichkit
et al. (53)
64  12 54 NR NR NR NR 36 69 55 36 42 55  13 NR 31
Gebker et al. (54) 63  10 67 48 NR 40 18 31 74 65 23 31 57  7 NR 40
Kelle et al. (55) 61  11 68 52 43 NR NR 25 73 70 17 44 57  10 NR 30
Korosoglou et al. (56) 65  13 74 55 NR 40 12 NR 71 53 19 18 60  12 NR 20
Median 62 59 43 23 18 10 24 64 58 24 29 61 24 29
Weighted mean 63  12 63 42 28 29 11 26 66 60 24 25 61  12 29 32
CABG ¼ coronary artery bypass graft surgery; LVEF ¼ left ventricular ejection fraction; MI ¼ myocardial infarction; NR ¼ not reported; PCI ¼ percutaneous coronary intervention; other abbreviations as in Table 1.
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Figure 2 Individual and Pooled Risk of Cardiovascular Outcomes for Stress CMR
Forest plots comparing clinical outcomes of patients with known or suspected coronary artery disease (CAD) with positive stress cardiac magnetic resonance imaging (CMR) and
negative stress CMR. Outcomes included (A) combined cardiovascular outcomes including cardiovascular death and nonfatal myocardial infarction (MI), (B) cardiovascular
death, and (C) nonfatal MI. CI ¼ conﬁdence interval.
Lipinski et al. JACC Vol. 62, No. 9, 2013
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832combined outcome AERs (Table 4, Fig. 5), patients with
LGE had signiﬁcantly worse outcomes than patients without
LGE (4.6  4.0% vs. 1.4  1.0%, respectively; T score ¼
2.45, p < 0.03). Of the 6 studies reporting cardiovascular
death during follow-up and presence of LGE (Fig. 4B),
patients with evidence of LGE had a higher incidence of
cardiovascular death during follow-up than patients without
LGE (OR: 2.71 [95% CI: 1.66 to 4.41]; p < 0.0001,
I2 ¼ 0%). When comparing cardiovascular death AERs,
patients with LGE had a signiﬁcantly greater risk than
patients without LGE (2.4  1.4% vs. 0.8  0.5%, respec-
tively; T score ¼ 2.54, p < 0.04). Of the 5 studies reporting
nonfatal MI during follow-up and presence of LGE
(Fig. 4C), patients with LGE had a trend toward a higher
incidence of MI during follow-up than patients without LGE
(OR: 3.29 [95% CI: 0.55 to 19.76]; p ¼ 0.19, I2 ¼ 59%).
However, when comparing MI AERs, patients with LGE
had a signiﬁcantly higher incidence of MI during follow-up
than patients without LGE (1.9  0.3% vs. 0.8  0.5%,
respectively; T score ¼ 3.66, p < 0.008).Assessment of publication bias. Funnel plots were visually
inspected for all outcomes for both assessment of ischemia
and LGE. There was no signiﬁcant asymmetry of the funnel
plots for the different outcomes though heterogeneity, with
an elevated I2 value noted in some outcomes (Figs. 2A and
2C). However, Peter’s test could not rule out the presence of
publication bias (R2 ¼ 0.16; p ¼ 0.15). Exclusion of 1 study
at a time from the outcomes analysis did not affect the
ﬁndings (data not shown).
Discussion
The ﬁndings of this systematic review and meta-analysis
show that stress CMR provides excellent prognostic strati-
ﬁcation of patients with known or suspected CAD. The data
demonstrate that patients with a stress CMR negative for
evidence of ischemia have <1% AER of either cardiovas-
cular death or nonfatal MI, whereas patients with ischemia
on stress CMR have a 5% AER of either cardiovascular
death or nonfatal MI. Furthermore, there was no signiﬁcant
Figure 2 Continued
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833difference between vasodilator stress CMR and dobutamine
stress CMR in terms of prognostic characteristics. This
ﬁnding is important because vasodilator stress CMR is being
used more frequently and has favorable characteristics givenits ease of performance. In addition, the presence of LGE
during CMR suggested an increased risk of MACE. Further
studies are necessary to determine whether LGE provides
incremental prognostic information in patients undergoing
Table 3
AERs of Studies for Combined Outcome of Cardiovascular Death and MI, Cardiovascular Death, and MI Comparing Patients
With Positive Stress CMR and Patients With a Negative Stress CMR
Studies
First Author (Ref. #)
Combined Event AER Cardiovascular Death AER Nonfatal MI AER
Positive Stress
CMR
Negative Stress
CMR
Positive Stress
CMR
Negative Stress
CMR
Positive Stress
CMR
Negative Stress
CMR
Vasodilator stress CMR studies
Bertaso et al. (38) 1.8 0.4 0 0.2 1.8 0.2
Bingham et al. (39) 2.9 0.8 2.6 0.6 0.3 0.2
Bodi et al. (40) 5.7 1.6 3.8 0.6 1.9 0.9
Buckert et al. (41) 3.6 0.9 2.2 0.5 1.4 0.4
Coelho-Filho et al. (42) 12.2 0.7 6.7 0.4 5.5 0.3
Doesch et al. (43) 7.1 0 0 0 7.1 0
Ingkanisorn et al. (44) 8.0 0 5.4 0 2.7 0
Jahnke et al. (45) 3.8 1.1 NR NR NR NR
Krittayaphong et al. (46) 2.7 0.3 NR NR NR NR
Lerakis et al. (47) 0 0 0 0 0 0
Lo et al. (48) 8.1 0.8 NR NR NR NR
Lubbers et al. (49) NR 0.4 NR 0 NR 0.4
Pilz et al. (50) NR 0 NR 0 NR 0
Steel et al. (51) 19.0 4.2 NR NR NR NR
Vogel-Claussen et al. (52) 0 0 0 0 0 0
Dobutamine stress CMR studies
Charoenpanichkit et al. (53) 5.6 2.3 NR NR NR NR
Gebker et al. (54) 4.3 0.4 1.0 0.2 3.3 0
Jahnke et al. (45) 3.8 1.5 NR NR NR NR
Kelle et al. (55) 2.2 0.8 NR NR NR NR
Korosoglou et al. (56) 8.0 0.2 2.2 0.04 5.8 0.2
Values are %.
AER ¼ annualized event rate; CMR ¼ cardiac magnetic resonance imaging; NR ¼ not reported; MI ¼ myocardial infarction.
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834stress CMR. The ﬁndings of this meta-analysis in a large
number of patients with a median follow-up of 25 months
support the role of stress CMR for identifying patients at
either low or high risk for future MACE.
Stress CMR has evolved into a powerful tool to provide
comprehensive cardiac assessment. This imaging modalityFigure 3 AERs of Cardiovascular Outcomes for Stress CMR
Weighted mean annualized event rates (AERs) for combined cardiovascular
outcome of cardiovascular death and nonfatal MI, cardiovascular death, and non-
fatal MI comparing patients with positive stress CMR (solid bars) and patients with
a negative stress CMR (open bars). Abbreviations as in Figure 2.not only provides assessment of ischemia but can also
identify the presence of LGE and valvular heart disease and
can assess cardiac structure and function. Our data suggest
that patients with a negative stress CMR have a prognosis
comparable to those patients who have a negative stress
myocardial perfusion imaging or stress echocardiogram
(57–60). The combined event rate of the included studies in
our meta-analysis was 5.1% during follow-up (AER 1.9%)
with 2.0% for cardiovascular death (AER 0.9%) and 1.9%
for nonfatal MI (AER 0.8%) in studies providing the
individual outcomes. The total cardiovascular death AER
was also comparable to that seen in patients undergoing
coronary computed tomographic angiography in the
CONFIRM (Coronary CT Angiography Evaluation for
Clinical Outcomes: An International Multicenter Registry)
trial (1.06%) (61). The robust prognostic data for stress
CMR suggest that this imaging modality should be
considered as an excellent alternative to stress nuclear
myocardial perfusion imaging and stress echocardiography
in patients who cannot exercise. This is especially true given
the excellent diagnostic characteristics of stress CMR for
CAD (1–4). Furthermore, research is currently underway to
explore the possibility of performing exercise stress CMR to
assess for myocardial ischemia (62), which may provide
further valuable exercise and electrocardiography data. Large
multicenter trials are currently accruing longer-term follow-
up data that will provide further valuable prognostic data for
Figure 4 Individual and Pooled Risk of Cardiovascular Outcomes Based on the Presence of LGE
Forest plots comparing clinical outcomes of patients with known or suspected CAD with late gadolinium enhancement (LGE) on CMR and without LGE on CMR. Outcomes included
(A) combined cardiovascular outcomes including cardiovascular death and nonfatal MI, (B) cardiovascular death, and (C) nonfatal MI. Abbreviations as in Figure 2.
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835stress CMR (CE-MARC [Cardiovascular Magnetic Reso-
nance and Single-Photon Emission Computed Tomog-
raphy for Diagnosis of Coronary Heart Disease] [4],
EuroCMR Registry [63], and MR-IMPACT-II [Magnetic
Resonance Imaging for Myocardial Perfusion Assessment
in Coronary Artery Disease] [3]). In the current ﬁnancial
environment, these ﬁndings provide justiﬁcation for
prospective randomized trials to assess the comparativeeffectiveness of stress CMR compared with alternative
stress-testing modalities.
Study limitations. Limitations of systematic reviews
pertinent to the current study include lack of raw and
uniform data from included studies, inclusion of different
stress modalities, variable censoring of data for patients that
underwent revascularization after stress CMR, estimation of
events from hazard ratios in some studies, which assumes
Table 4
AERs of Studies for Combined Outcome of Cardiovascular Death and Nonfatal MI, Cardiovascular Death, and
Nonfatal MI Comparing Patients With LGE on CMR and Patients Without LGE on CMR
Stress CMR Studies
First Author (Ref. #)
Combined Event AER Cardiovascular Death AER Nonfatal MI AER
LGE Present LGE Absent LGE Present LGE Absent LGE Present LGE Absent
Bertaso et al. (38) 2.2 0.4 0 0.2 2.2 0.2
Bingham et al. (39) 2.0 0.9 1.4 0.7 NR NR
Bodi et al. (40) 5.5 2.4 3.6 1.3 1.9 1.1
Coelho-Filho et al. (42) 6.7 2.2 NR NR NR NR
Krittayaphong et al. (46) 2.4 0.6 NR NR NR NR
Lerakis et al. (47) 0 0 0 0 0 0
Lo et al. (48) 9.4 1.1 NR NR NR NR
Pilz et al. (50) 0 NR 0 NR 0
Steel et al. (51) 18.9 3.5 NR NR NR NR
Vogel-Claussen et al. (52) 0 0 0 0 0% 0
Values are %.
AER ¼ annualized event rate; CMR ¼ cardiac magnetic resonance imaging; LGE ¼ late gadolinium enhancement; NR ¼ not reported; MI ¼ myocardial infarction.
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836a linear event rate, and differences in length of follow-up (for
which we attempted to adjust for by using AERs). Another
limitation was the inability to assess prognosis and the
degree of ischemia on stress CMR. We also included single-
center, retrospective studies, as well as studies that only
reported data on patients with negative stress tests. The
studies in this systematic review used magnets with a ﬁeld
strength of 1.5-T, but the data regarding 3.0-T imaging
were limited. Another limitation is the lack of information
regarding the adequacy of medical therapy after stress CMR.
In addition, there is the possibility of publication bias, as
small studies may have been performed that did not show
a signiﬁcant difference in prognosis and were not published.
Although the random-effects pooling method adjusts for it,
another limitation of this meta-analysis was the heteroge-
neity observed between studies. Overall pooling can be
fraught with signiﬁcant heterogeneity and inconsistency.Figure 5
AERs of Cardiovascular Outcomes Based on the
Presence of LGE
Weighted mean AERs for combined cardiovascular outcome of cardiovascular
death and nonfatal MI, cardiovascular death, and nonfatal MI comparing patients
with LGE on CMR (solid bars) and patients without LGE on CMR (open bars).
Abbreviations as in Figures 2 to 4.Finally, meta-regression techniques are limited because we
did not have access to all the raw patient information and
therefore can only assess the correlation between the variable
prevalence in a study and the outcome, and the results
should thus be viewed with caution and as hypothesis-
generating.
Conclusions
Stress CMR seems to provide excellent prognostic risk
stratiﬁcation for patients with known or suspected CAD. In
addition, patients with the presence of LGE on CMR are at
increased risk of cardiovascular death or nonfatal MI. Stress
CMR seems comparable to other stress-testing modalities
for assessment of prognostic risk.
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